Back to companies

Forma Therapeutics Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Forma Therapeutics Inc (Forma), a subsidiary of Novo Nordisk AS, is a biotech company. It develops technologies to identify the initial molecules that provide drug discovery programs. The company's pipeline products include etavopivat, hbf inducer, membrane stabilizer, FT-7051, FT-3171, synthetic lethality, olutasidenib and B1-1701963 among others. It offers services for hematological disease, acute myeloid leukemia, brain tumors, sickle cell disease and others. The company collaborates with biotechnology companies, pharmaceuticals and biomedicine companies and research institutes for its research and development activities. It operates offices in Watertown and Branford, the US. FORMA is headquartered in Watertown, Massachusetts, the US.

Gain a 360-degree view of Forma Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Forma Therapeutics Inc and make more informed decisions for your business Register your interest
Headquarters United States of America

Address Suite 501, 300 North Beacon Street, Watertown, Massachusetts, 02472


Telephone +1 617 6791970

Industry Pharmaceuticals and Healthcare

   

Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest
Image for loader
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Forma Therapeutics Inc key executives to enhance your sales strategy Gain insight into Forma Therapeutics Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?